Brief: Fusion Pharmaceuticals Says Deal Provides For Payment By Fusion To Astrazeneca AB Termination Fee Of $71.7 Million If Deal Terminated In Some Circumstances

Fusion Pharmaceuticals

19/03/2024 10:35

March 19 (Reuters) - AstraZeneca PLC  AZN.L :
    * FUSION PHARMACEUTICALS- DEAL PROVIDES FOR PAYMENT BY
FUSION TO
ASTRAZENECA AB TERMINATION FEE OF $71.7 MILLION IF DEAL
TERMINATED IN SOME CIRCUMSTANCES
    * FUSION PHARMACEUTICALS: UNDER DEAL, PAYMENT BY ASTRAZENECA
AB TO
CO OF A TERMINATION FEE OF $102.4 MILLION IF DEAL IS TERMINATED
UNDER SOME CIRCUMSTANCES

Source text for Eikon:  ID:n0001193125-24-070701 
Further company coverage:  AZN.L 

 ((Reuters.Briefs@thomsonreuters.com;))